Abstract
Vesicoureteral reflux (VUR) is the abnormal retrograde flow of urine from the bladder into the upper urinary tract. Diagnosis and subsequent management of VUR have become increasingly controversial, with differing opinions over which children should be evaluated for reflux, and when detected, who should undergo treatment. Management goals include prevention of recurrent febrile urinary tract infection (fUTI) and renal injury while minimizing the morbidity of treatment and follow-up. Management options include observation with or without continuous antibiotic prophylaxis and surgical correction via endoscopic, open or laparoscopic/robotic approaches. Management should be individualized and based on patient age, health, risk of subsequent renal injury, clinical course, renal function, and parental preference.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30:587–93.
Skoog SJ, Peters CA, Arant Jr BS, et al. Pediatric vesicoureteral reflux guideline panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol. 2010;184:1145–51.
Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection? JAMA. 2007;298:2895–904.
Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184:265–73.
Nguyen HT, Herndon CD, Cooper C, et al. Nguyen HT, Herndon CD, Cooper C, et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 2010;6:212. J Pediatr Urol. 2010;6:212–31.
Knudson MJ, Austin JC, Wald M, et al. Computational model for predicting the chance of early resolution in children with vesicoureteral reflux. J Urol. 2007;178:1824–7.
Peters CA, Skoog SJ, Arant Jr BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184:1134–44.
Knudson MJ, Austin JC, McMillan ZM, et al. Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol. 2007;178:1684–8.
Koyle M, Kirsch A, Barone C, et al. Challenges in childhood urinary tract infection/vesicoureteral reflux investigation and management: calming the storm. Urology. 2012;80:503–8.
Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–609.
Juliano TM, Stephany HA, Clayton DB, et al. Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old. J Urol. 2013;190:1505–10.
Nelson CP, Johnson EK, Logvinenko T, et al. Ultrasound as a screening test for genitourinary anomalies in children with UTI. Pediatrics. 2014;133:e394–403.
Arlen AM, Merriman LS, Kirsch JM, et al. Early Effect of American Academy of Pediatrics UTI Guidelines on Radiographic Imaging and Diagnosis of Vesicoureteral Reflux in the Emergency Room Setting. J Urol 2014. doi: 10.1016/j.juro.2014.06.100.
Wan J, Skoog SJ, Hulbert WC, et al. Executive Committee, Section on Urology, American Academy of Pediatrics. Section on Urology Response to new Guidelines for the diagnosis and management of UTI. Pediatrics. 2012;129:e1051–3.
The RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, et al. Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux. N Engl J Med. 2014;370:2367–76. Multi-institutional, randomized, placebo-controlled study demonstrating that antibiotic prophylaxis is associated with a substantially reduced risk of recurrent infections in children with vesicoureteral reflux.
Brandstrom P, Esbjorner E, Herthelius, et al. The Swedish Reflux Trial in Children: III. Urinary tract infection pattern. J Urol. 2010;184:286–91. Multi-institutional, randomized, controlled trial demonstrating a high rate of recurrent febrile urinary tract infections in girls older than one year of age with dilating reflux. Antibiotic prophylaxis and endoscopic injection were associated with decreased infection rate.
Wheeler DM, Vimalachandra D, Hodson EM, et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2004;3:CD001532.
Nguyen HT, Benson CB, Bromley B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014;10:982–98. Multidisciplinary panel consensus on postnatal urinary tract dilation with accompanying follow-up algorithm based on the proposed classification system.
Cheng CH, Tsai MH, Huang YC, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics. 2008;122:1212–7.
National Collaborating Centre for Women’s and Children’s Health. National Institute for Health and Clinical Excellence (NICE) Guideline. Urinary Tract Infection in Children: Diagnosis, Treatment and Long-term Management. London: RCOG Press; 2007. http://www.nice.org.uk/nicemedia/pdf/CG54fullguideline.pdf.
Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl Med. 2009;361:1748–59.
Elder JS, Peters CA, Arant Jr BS, et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157:1846–51.
Alexander SE, Arlen AM, Storm DW, et al. Bladder Volume at Onset of Vesicoureteral Reflux is an Independent Risk Factor for Breakthrough Febrile Urinary Tract Infection. J Urol. 2015;193:1342–6. Retrospective study where bladder volume at VUR onset was normalized for age; children with vesicoureteral reflux at low bladder volumes were found to be at increased risk for breakthrough febrile urinary tract infections.
Sung J, Skoog S. Surgical management of vesicoureteral reflux in children. Pediatr Nephrol. 2012;27:551–61.
Cooper CS, Chung BI, Kirsch AJ, et al. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol. 2000;163:269–72.
Al-Sayyad AJ, Pike JG, Leonard MP. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol. 2005;174:1587–9.
Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674–9.
Saadeh SA, Mattoo TK. Managing urinary tract infections. Pediatr Nephrol. 2011;26:1967–76.
Mak RH, Kuo HJ. Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr. 2006;18:148–52.
Schwab CW, Wu H, Selman H, et al. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol. 2002;168:2594–9.
Sjostrom S, Sillen U, Bachelard M, et al. Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol. 2004;172:694–8.
Lin KY, Chiu NT, Chen MJ, et al. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol. 2003;18:362–5.
McMillian ZM, Austin JC, Knudson MJ, et al. Bladder volume at onset of reflux on initial cystogram predicts spontaneous resolution. J Urol. 2006;176:1838–41.
O’Donnell B, Puri P. Treatment of vesicoureteral reflux by endoscopic injection of Teflon. Br Med J. 1984;289:7–9.
Kirsch AJ, Perez-Brayfield M, Scherz HC. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol. 2004;171:2413–6.
Lackgren G, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux. BJUI. 2010;105:1332–47.
Lendvay TS, Sorensen M, Cowan CA, et al. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database review. J Urol. 2006;176:1864–7.
Nelson CP, Copp HL, Lai J, et al. Is availability of endoscopy changing initial management of vesicoureteral reflux? J Urol. 2009;182:1152–7.
Kaye JD, Srinivasan AK, Delaney C, et al. Clinical and radiographic results of endoscopic injection for vesicoureteral reflux: Defining measures of success. J Pediatr Urol. 2012;8:297–303.
Kalisvaart JF, Scherz HC, Cuda S, et al. Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesicoureteral reflux. J Pediatr Urol. 2012;8:359–65.
Arlen AM, Scherz HC, Fillimon E, et al. Is routine voiding cystourethrogram necessary following double HIT for primary vesicoureteral reflux? J Pediatr Urol. 2015. doi:10.1016/j.jpurol.2014.11.011.
Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: Systemic Review. Pediatrics. 2010;125:1010–9.
Elder JS, Diaz M, Calamone AA, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006;175:716–22.
Arlen AM, Pakalniskis BL, Cooper CS. Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral reflux. J Pediatr Urol. 2012;8:e27–30.
Ehrlich RM, Gershman A, Fuchs G. Laparoscopic vesicoureteroplasty in children; initial case reports. Urol. 1994;433:255–61.
Janetschek G, Radmayr C, Bartsch G. Laparoscopic ureteral anti-reflux plasty reimplantation; first clinical experience. Ann Urol. 1995;29:101–5.
Atala A, Kavoussi LR, Goldstein DS, et al. Laparoscopic correction of vesicoureteral reflux. J Urol. 1993;150:748–51.
Peters CA, Woo R. Intravesical robotically assisted bilateral ureteral reimplantation. J Endourol. 2005;19:618–22.
Casale P, Patel RP, Kolon TF. Nerve sparing robotic extravesical ureteral reimplantation. J Urol. 2008;179:1987–90.
Gundeti MS, Kojima Y, Haga N, et al. Robotic-assisted laparoscopic reconstructive surgery in the lower urinary tract. Curr Urol Rep. 2013;14:333–41.
Marchini GS, Hong YK, Minnillo BJ, et al. Robotic assisted laparoscopic ureteral reimplantation in children: case matched comparative study with open surgical approach. J Urol. 2011;185:1870–5.
Smith RP, Oliver JL, Peters CA. Pediatric robotic extravesical ureteral reimplantation: comparison with open surgery. J Urol. 2011;185:1876–81.
Stanasel I, Atala A, Hemal A. Robotic assisted ureteral reimplantation: current status. Curr Urol Rep. 2013;14:32–6.
Akhavan A, Avery D, Lendvay TS. Robot-assisted extravesical ureteral reimplantation: outcomes and conclusions from 78 ureters. J Pediatr Urol. 2014;10:864–8.
Grimsby GM, Dwyer ME, Jacobs MA, et al. Multi-Institutional Review of Outcomes of Robot-Assisted Laparoscopic Extravesical Ureteral Reimplantation. J Urol. 2014. doi:10.1016/j.juro.2014.07.128.
Dangle PP, Shah A, Gundeti MS. Robot-assisted laparoscopic ureteric reimplantation: extravesical technique. BJU Int. 2014;114:630–2.
Cooper CS, Austin JC. Vesicoureteral reflux: who benefits from surgery? Urol Clin N Am. 2004;31:535–41.
Jodal U, Smellie JM, Lax H, et al. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol. 2006;21:785–92.
Compliance with Ethics Guidelines
Conflict of Interest
Angela M. Arlen and Christopher S. Cooper declare no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is part of the Topical Collection on Pediatric Urology
Rights and permissions
About this article
Cite this article
Arlen, A.M., Cooper, C.S. Controversies in the Management of Vesicoureteral Reflux. Curr Urol Rep 16, 64 (2015). https://doi.org/10.1007/s11934-015-0538-2
Published:
DOI: https://doi.org/10.1007/s11934-015-0538-2